These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 25897647)

  • 1. The potential of flavonoids in the treatment of non-alcoholic fatty liver disease.
    Van De Wier B; Koek GH; Bast A; Haenen GR
    Crit Rev Food Sci Nutr; 2017 Mar; 57(4):834-855. PubMed ID: 25897647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatoprotective Effect of Loquat Leaf Flavonoids in PM
    Jian T; Ding X; Wu Y; Ren B; Li W; Lv H; Chen J
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30275422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flavonoids and Related Compounds in Non-Alcoholic Fatty Liver Disease Therapy.
    Pisonero-Vaquero S; González-Gallego J; Sánchez-Campos S; García-Mediavilla MV
    Curr Med Chem; 2015; 22(25):2991-3012. PubMed ID: 26242257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-alcoholic Fatty Liver Disease: Beneficial Effects of Flavonoids.
    Akhlaghi M
    Phytother Res; 2016 Oct; 30(10):1559-1571. PubMed ID: 27307131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current and Potential Future Pharmacological Approaches for Non- Alcoholic Fatty Liver Disease.
    Imprialos K; Stavropoulos K; Bouloukou S; Kerpiniotis G; Karagiannis A; Doumas M
    Curr Vasc Pharmacol; 2018; 16(3):276-288. PubMed ID: 28676020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary Polyphenols and Non-Alcoholic Fatty Liver Disease.
    Abenavoli L; Larussa T; Corea A; Procopio AC; Boccuto L; Dallio M; Federico A; Luzza F
    Nutrients; 2021 Feb; 13(2):. PubMed ID: 33546130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preventive effects of citrulline on Western diet-induced non-alcoholic fatty liver disease in rats.
    Jegatheesan P; Beutheu S; Freese K; Waligora-Dupriet AJ; Nubret E; Butel MJ; Bergheim I; De Bandt JP
    Br J Nutr; 2016 Jul; 116(2):191-203. PubMed ID: 27197843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural antioxidants for non-alcoholic fatty liver disease: molecular targets and clinical perspectives.
    Salomone F; Godos J; Zelber-Sagi S
    Liver Int; 2016 Jan; 36(1):5-20. PubMed ID: 26436447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The great potential of flavonoids as candidate drugs for NAFLD.
    Li L; Qin Y; Xin X; Wang S; Liu Z; Feng X
    Biomed Pharmacother; 2023 Aug; 164():114991. PubMed ID: 37302319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-alcoholic fatty liver disease and flavonoids: Current perspectives.
    Shin JH; Jung JH
    Clin Res Hepatol Gastroenterol; 2017 Feb; 41(1):17-24. PubMed ID: 27545758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-alcoholic fatty liver disease and dyslipidemia: An update.
    Katsiki N; Mikhailidis DP; Mantzoros CS
    Metabolism; 2016 Aug; 65(8):1109-23. PubMed ID: 27237577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of nutraceuticals for the treatment of non-alcoholic fatty liver disease.
    Del Ben M; Polimeni L; Baratta F; Pastori D; Angelico F
    Br J Clin Pharmacol; 2017 Jan; 83(1):88-95. PubMed ID: 26852185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpinetin improved high fat diet-induced non-alcoholic fatty liver disease (NAFLD) through improving oxidative stress, inflammatory response and lipid metabolism.
    Zhou Y; Ding YL; Zhang JL; Zhang P; Wang JQ; Li ZH
    Biomed Pharmacother; 2018 Jan; 97():1397-1408. PubMed ID: 29156529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Micronutrient Antioxidants and Nonalcoholic Fatty Liver Disease.
    Chen G; Ni Y; Nagata N; Xu L; Ota T
    Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27563875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current pharmacological therapies for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
    Takahashi Y; Sugimoto K; Inui H; Fukusato T
    World J Gastroenterol; 2015 Apr; 21(13):3777-85. PubMed ID: 25852263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural Active Compounds from Plant Food and Chinese Herbal Medicine for Nonalcoholic Fatty Liver Disease.
    Liu Q; Zhu L; Cheng C; Hu YY; Feng Q
    Curr Pharm Des; 2017; 23(34):5136-5162. PubMed ID: 28925892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 as a double-edged sword in the progression of non-alcoholic fatty liver disease.
    Yan Z; Miao X; Zhang B; Xie J
    Life Sci; 2018 Dec; 215():64-72. PubMed ID: 30473026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid oxidation products in the pathogenesis of non-alcoholic steatohepatitis.
    Bellanti F; Villani R; Facciorusso A; Vendemiale G; Serviddio G
    Free Radic Biol Med; 2017 Oct; 111():173-185. PubMed ID: 28109892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Citrulline decreases hepatic endotoxin-induced injury in fructose-induced non-alcoholic liver disease: an ex vivo study in the isolated perfused rat liver.
    Ouelaa W; Jegatheesan P; M'bouyou-Boungou J; Vicente C; Nakib S; Nubret E; De Bandt JP
    Br J Nutr; 2017 Jun; 117(11):1487-1494. PubMed ID: 28637520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New insight and potential therapy for NAFLD: CYP2E1 and flavonoids.
    Wang K; Tan W; Liu X; Deng L; Huang L; Wang X; Gao X
    Biomed Pharmacother; 2021 May; 137():111326. PubMed ID: 33556870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.